HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 6, Pages 1080-1088
Publisher
Springer Nature
Online
2014-08-01
DOI
10.1038/bjc.2014.423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses
- (2013) C. M. Sungur et al. BLOOD
- KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts
- (2013) E. Marcenaro et al. BLOOD
- NK Cell Tolerance of Self-Specific Activating Receptor KIR2DS1 in Individuals with Cognate HLA-C2 Ligand
- (2013) G. Pittari et al. JOURNAL OF IMMUNOLOGY
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conflicting Impact of Alloreactive NK Cells on Transplantation Outcomes after Haploidentical Transplantation: Do the Reconstitution Kinetics of Natural Killer Cells Create These Differences?
- (2011) Xiang-Yu Zhao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT
- (2011) S. Sivori et al. BLOOD
- Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase
- (2011) Q. Jiang et al. BLOOD
- Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation
- (2011) Emanuela Marcenaro et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Natural Killer Cell Mediated Missing-Self Recognition Can Protect Mice from Primary Chronic Myeloid Leukemia In Vivo
- (2011) Mika Kijima et al. PLoS One
- Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
- (2010) I. H. Gabriel et al. BLOOD
- Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children
- (2010) M. M. Pfeiffer et al. HAEMATOLOGICA
- HLA-Haploidentical Stem Cell Transplantation for Hematologic Malignancies
- (2009) Ephraim J. Fuchs et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
- (2009) Heather J. Symons et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Current status of haploidentical stem cell transplantation for leukemia
- (2009) Xiao-jun Huang Journal of Hematology & Oncology
- Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies
- (2009) B M Triplett et al. LEUKEMIA
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- HLA-mismatched/haploidentical hematopoietic stem cell transplantation withoutin vitroT cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase
- (2008) Huang Xiao-jun et al. ANNALS OF MEDICINE
- Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
- (2008) L. Vago et al. BLOOD
- Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib
- (2008) A. S. M. Yong et al. BLOOD
- MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response
- (2008) M. Yawata et al. BLOOD
- Continuous engagement of a self-specific activation receptor induces NK cell tolerance
- (2008) Sandeep K. Tripathy et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now